![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Biotest AG | TG:BIO | Tradegate | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 41.60 | 41.60 | 42.40 | 0.00 | 14:18:06 |
RNS Number:4655L BioFocus PLC 23 May 2003 BIOFOCUS PLC 23 MAY 2003 BioFocus to Consolidate Operations in Cambridge Area BioFocus today announced its intention to consolidate the Sittingbourne operation at its Chesterford Park location. The consolidation will see the relocation of staff from its Sittingbourne premises to Chesterford Park. Operations on the Sittingbourne site will close by the end of 2003. Over the past 12 months, the company has looked at various options to bring its operations together, including the building of a new facility. The change in the biotech property market has enabled BioFocus to negotiate Heads of Terms for a 5-year lease on an existing building at Chesterford Park, which has become available as a result of the downsizing of another company. Consequently, the cost of this exercise will be reduced from an anticipated #4-5m to less than #1m. The Company will continue to operate its Biology division from the existing facility on the Cambridge Science Park. Commenting on this, Geoff McMillan, Chief Executive, stated "The unanticipated availability of suitable laboratory and office space next to our existing premises at Chesterford Park presents a great opportunity to accelerate the consolidation of our business into the Cambridge area. It will also provide sufficient growth potential and enable us to realise both scientific and business synergies. We will incur a one off restructuring and refurbishing charge in 2003 which should not exceed #1m, however we will not now need to incur the cost of building a new facility, as previously planned. Operating costs will also be held at current levels." Enquires: BioFocus Plc 01799 533500 Stephen France END This information is provided by RNS The company news service from the London Stock Exchange END MSCUUVNROSRVUAR
1 Year Biotest Chart |
1 Month Biotest Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions